Zenas BioPharma

📍 Waltham, United States👥 93 employees💰 Last funded May 2024
Biotechnology Research🌐 zenasbio.com
Website LinkedIn
Zenas BioPharma is a global biopharmaceutical company committed to becoming a leader in the development and delivery of immune-based therapies for patients around the world. Zenas is rapidly advancing a deep portfolio of innovative therapeutics that continues to grow through our successful business development strategy. Our experienced leadership team and network of business partners drive operational excellence to deliver potentially transformative therapies to improve the lives of those facing autoimmune and rare diseases. For more information about Zenas BioPharma, please visit www.zenasbio.com.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Zenas BioPharma?
Zenas BioPharma has 2 investors on record on gritt.io.
When did Zenas BioPharma last raise funding?
The most recent investment in Zenas BioPharma recorded on gritt.io was in May 2024.
What industry is Zenas BioPharma in?
Zenas BioPharma operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Zenas BioPharma based?
Zenas BioPharma is headquartered in Waltham, United States.